Endo Sheds Drugs To Ease FTC Concerns Over $8B Par Buy
The Federal Trade Commission said on Friday that Endo International PLC will sell New Jersey-based Rising Pharmaceuticals its rights to ulcer and thyroid drugs to address the commission's antitrust concerns over...To view the full article, register now.
Already a subscriber? Click here to view full article